Cargando…
4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression
BACKGROUND: 4-Methylumbelliferone (4-MU), a hyaluronan (HA) synthesis inhibitor, has antitumor activity in cancer cells. However, few studies have focused on its effects on ovarian cancer. The aim of this study was to investigate the effects of 4-MU on ovarian cancer and to elucidate its mechanism o...
Autores principales: | Tamura, Ryosuke, Yokoyama, Yoshihito, Yoshida, Hidemi, Imaizumi, Tadaatsu, Mizunuma, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198731/ https://www.ncbi.nlm.nih.gov/pubmed/25304388 http://dx.doi.org/10.1186/s13048-014-0094-2 |
Ejemplares similares
-
The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer
por: Matsushita, Yoko, et al.
Publicado: (2014) -
Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice
por: Hirakawa, Hachidai, et al.
Publicado: (2014) -
Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
por: Hata, K, et al.
Publicado: (1999) -
Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase
por: Harada, Naomoto, et al.
Publicado: (2023) -
The cytosol activity of thymidine phosphorylase in endometrial cancer
por: Miszczak-Zaborska, Elżbieta, et al.
Publicado: (2008)